Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05311618 |
| Title | Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | NGM Biopharmaceuticals, Inc |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| SCRI Denver | Denver | Colorado | 80218 | United States | Details | |
| Yale Cancer Center | New Haven | Connecticut | 06520 | United States | Details | |
| Henry Ford Health System | Detroit | Michigan | 48202 | United States | Details | |
| START Midwest | Grand Rapids | Michigan | 49546 | United States | Details | |
| Mount Sinai Hospital | New York | New York | 10029 | United States | Details | |
| MD Anderson | Houston | Texas | 77030 | United States | Details |